1. 10 year-experience of a referral center
Abstract ID: 
Moderated Poster - MP26
Thulium laser conservative treatment of upper tract urinary cancer (UTUC):
10 year-experience of a referral center
Defidio L1, De Dominicis M1,Di Gianfrancesco L2, Patel A3
1Cristo Re Hospital, Dept. of Urology, Rome, Italy
2Catholic School of Medicine, Rome, Italy
3 London, UK

2. Thulium vs. Holmium Laser UTUC Ablation
Thulium laser conservative treatment of upper tract urinary cancer (UTUC): 10 year-experience of a referral center
Thulium vs. Holmium Laser UTUC Ablation
59 UTUC pts
from 2005 to 2009
Thulium Laser Ablation
vs. Holmium laser experience pre-2005
SAFETY
Better fiber stability
Better precision
Better coagulation
Reduced bleeding
Improved vision
Reduced mucosal perforation
Reduced op. time for tumor > 1.5 cm
ONCOLOGICAL EFFICACY
“The Thulium laser delivered non-inferior tumor outcomes”
Thulium-Holmium:YAG laser (Revolix-Duo, Lisa Laser®)
(10 watts, 270 µm fiber)
EAU guidelines follow-up scheme

3. in 123 pts (84,2%) selected for renal conservation therapy
Thulium laser conservative treatment of upper tract urinary cancer (UTUC): 10 year-experience of a referral center
146 patients from 2005 to 2016
3 month
F-U
Last
Recurrence-free rate
35.6%
41.8%
Recurrence rate
48.6%
37.7%
Nephro-ureterectomy
15.8%
20.5%
Mean age: 70.7 yrs (19-91)
Median follow-up: 36.7mths (12-120)
Imperative cases (palliativ %
Bilateral %
Multifocal %
>1 cm tumors %
Above UPJ %
Below UPJ %
Sync Above + Below UPJ 13.7%
HG %
LG %*
Kidney Preserving Rate
91.8%
in 123 pts (84,2%) selected for renal conservation therapy
Conservative treatment of UTUC patients using the Thulium-Holmium:YAG Duo laser in a national referral center was Safe + Oncologically Effective over a 10 year period